These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

655 related items for PubMed ID: 19370615

  • 1. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Navaneethan SD, Perkovic V, Johnson DW, Nigwekar SU, Craig JC, Strippoli GF.
    Cochrane Database Syst Rev; 2009 Apr 15; (2):CD005019. PubMed ID: 19370615
    [Abstract] [Full Text] [Related]

  • 2. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Palmer SC, Navaneethan SD, Craig JC, Perkovic V, Johnson DW, Nigwekar SU, Hegbrant J, Strippoli GF.
    Cochrane Database Syst Rev; 2014 Jan 28; 2014(1):CD005019. PubMed ID: 24470059
    [Abstract] [Full Text] [Related]

  • 3. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF.
    Cochrane Database Syst Rev; 2009 Jul 08; (3):CD004289. PubMed ID: 19588351
    [Abstract] [Full Text] [Related]

  • 4. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF.
    Cochrane Database Syst Rev; 2009 Apr 15; (2):CD004289. PubMed ID: 19370598
    [Abstract] [Full Text] [Related]

  • 5. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Navaneethan SD, Pansini F, Perkovic V, Manno C, Pellegrini F, Johnson DW, Craig JC, Strippoli GF.
    Cochrane Database Syst Rev; 2009 Apr 15; (2):CD007784. PubMed ID: 19370693
    [Abstract] [Full Text] [Related]

  • 6. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Navaneethan SD, Shrivastava R.
    Cochrane Database Syst Rev; 2004 Oct 18; (4):CD004289. PubMed ID: 15495097
    [Abstract] [Full Text] [Related]

  • 7. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Hegbrant J, Strippoli GF.
    Cochrane Database Syst Rev; 2014 May 31; (5):CD007784. PubMed ID: 24880031
    [Abstract] [Full Text] [Related]

  • 8. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Nigwekar SU, Hegbrant J, Strippoli GF.
    Cochrane Database Syst Rev; 2013 Sep 11; 2013(9):CD004289. PubMed ID: 24022428
    [Abstract] [Full Text] [Related]

  • 9. Lipid-lowering agents for nephrotic syndrome.
    Kong X, Yuan H, Fan J, Li Z, Wu T, Jiang L.
    Cochrane Database Syst Rev; 2013 Dec 10; (12):CD005425. PubMed ID: 24327265
    [Abstract] [Full Text] [Related]

  • 10. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
    Zhan S, Tang M, Liu F, Xia P, Shu M, Wu X.
    Cochrane Database Syst Rev; 2018 Nov 19; 11(11):CD012502. PubMed ID: 30480766
    [Abstract] [Full Text] [Related]

  • 11. Fish oil for kidney transplant recipients.
    Lim AK, Manley KJ, Roberts MA, Fraenkel MB.
    Cochrane Database Syst Rev; 2007 Apr 18; (2):CD005282. PubMed ID: 17443580
    [Abstract] [Full Text] [Related]

  • 12. Immunosuppressive T-cell antibody induction for heart transplant recipients.
    Penninga L, Møller CH, Gustafsson F, Gluud C, Steinbrüchel DA.
    Cochrane Database Syst Rev; 2013 Dec 02; 2013(12):CD008842. PubMed ID: 24297433
    [Abstract] [Full Text] [Related]

  • 13. Fish oil for kidney transplant recipients.
    Lim AK, Manley KJ, Roberts MA, Fraenkel MB.
    Cochrane Database Syst Rev; 2016 Aug 18; 2016(8):CD005282. PubMed ID: 27535773
    [Abstract] [Full Text] [Related]

  • 14. Statins for the primary prevention of cardiovascular disease.
    Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, Ward K, Ebrahim S.
    Cochrane Database Syst Rev; 2013 Jan 31; 2013(1):CD004816. PubMed ID: 23440795
    [Abstract] [Full Text] [Related]

  • 15. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials.
    Strippoli GF, Navaneethan SD, Johnson DW, Perkovic V, Pellegrini F, Nicolucci A, Craig JC.
    BMJ; 2008 Mar 22; 336(7645):645-51. PubMed ID: 18299289
    [Abstract] [Full Text] [Related]

  • 16. Steroid avoidance or withdrawal for kidney transplant recipients.
    Pascual J, Zamora J, Galeano C, Royuela A, Quereda C.
    Cochrane Database Syst Rev; 2009 Jan 21; (1):CD005632. PubMed ID: 19160257
    [Abstract] [Full Text] [Related]

  • 17. Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery.
    Sanders RD, Nicholson A, Lewis SR, Smith AF, Alderson P.
    Cochrane Database Syst Rev; 2013 Jul 03; 2013(7):CD009971. PubMed ID: 23824754
    [Abstract] [Full Text] [Related]

  • 18. Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients.
    Montero N, Webster AC, Royuela A, Zamora J, Crespo Barrio M, Pascual J.
    Cochrane Database Syst Rev; 2014 Sep 15; 2014(9):CD007669. PubMed ID: 25220222
    [Abstract] [Full Text] [Related]

  • 19. Antibiotics for asymptomatic bacteriuria in kidney transplant recipients.
    Coussement J, Scemla A, Abramowicz D, Nagler EV, Webster AC.
    Cochrane Database Syst Rev; 2018 Feb 01; 2(2):CD011357. PubMed ID: 29390169
    [Abstract] [Full Text] [Related]

  • 20. Steroid avoidance or withdrawal for kidney transplant recipients.
    Haller MC, Royuela A, Nagler EV, Pascual J, Webster AC.
    Cochrane Database Syst Rev; 2016 Aug 22; 2016(8):CD005632. PubMed ID: 27546100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.